Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Tim's Corner: Picks & Pans From This High Yield Sector

"Fear cuts deeper than swords." ― George R.R. Martin, A Game of Thrones

George R.R. Martin

This instablog post comes from Tim Plaehn, expert on income investing and a friend & colleague of mine at Investors Alley as well as a contributor here on SeekingAlpha. Tim runs the Dividend Hunter newsletter which offers a solid & diverse selection of attractive high yield plays. The service is now over 5,200 active subscribers and can be had HERE for the rock bottom price of $49 for the first year.

Tim's Corner:

By Tim Plaehn,

Shrinking stock prices caused by failing businesses have raised the yields of these three stock to enticing levels, but don't be lured in by these eye-popping yields. These stocks have high yields for the wrong reasons and should be sold immediately before their stock prices come tumbling down.

Business Development Companies {BDCs) have a lot in common with closed-end funds, or CEFs. However, investors need to take a very different approach to the basic evaluation of these two types of high-yield investments. While a share price discount to net asset value {NAV} can be a positive with a quality CEF, when you see a BDC trading at a discount to NAV, view that as a very strong negative and a reason to avoid or sell the stock.

Business development companies make up a small stock market sector operating under a highly specific structure and tax rules. The business development company type was created by Congress to facilitate the availability of debt and equity capital for growing small to mid-size corporations.

To stay within its legal limits, a BDC will only provide capital to corporations that are too small to be able to tap into the public debt and equity markets. The large majority of BDC business is making loans to client companies. A BDC may also get a small equity stake in those clients, but you can view the BDC sector as a group of commercial lenders.

The biggest problem with the BDC business structure and the BDC rules is that one of these companies is not allowed to set aside bad loan reserves. By rules, a BDC must pay out over 90% of net income as dividends to investors. A regular bank can retain earnings against loans that don't get paid back; where as a BDC cannot.

This problem is compounded by the fact that BDCs make riskier loans. Their clients are the companies that cannot get regular commercial loans from banks. The facts of riskier loans and no loan loss reserves leads to the unavoidable fact that a BDC will have an unavoidable book value or NAV erosion from the percentage of loans that don't get repaid. On average 4% to 5% of the lending amount in the BDC universe will end up in default. In a recession, that percentage will go significantly higher.

A BDC counteracts the inevitable NAV erosion by steadily growing its book of loans. A BDC can never stand still. If it is not trying to grow, it will have a shrinking portfolio. That growth requires additional capital.

Another BDC rule limits the amount of debt a company can carry to be no more than one times the equity. This rule means that to fund growth, a BDC must regularly issue new shares of common stock. This is where the market share price vs. NAV becomes an issue.

If the stock price of a BDC is trading at a discount, it will receive less money if new shares are issued. In fact, the charters of many BDCs do not allow management to sell shares at a discount. This could keep a BDC from growing, and we now know that if it's not growing it will be fading away, continuing to lose book value and the share price will fall even farther.

On the flip side, if a BDC stock is trading at a premium to book value, the company gets an automatic NAV boost when new shares are sold. For example, if the stock is at a 20% premium to NAV, the company would get $1.2 million in cash when it sells $1 million in NAV of new shares.

Here are three popular BDCs that currently trade at significant discounts to their NAVs. Avoid or sell these stocks:

Medley Capital Corp(NYSE: MCC) has a market cap of $416 million and currently yields 11.4%. The MCC share price is trading at an 18% discount to NAV.
PennantPark Investment Corp.(NASDAQ: PNNT) has a market value of $580 million and yields 8.9%. PNNT trades at an 11% discount to NAV.
• Small cap BDC Garrison Capital Inc. (NASDAQ: GARS) yields 11.5%. This company has a market cap of $150 million. The GARS market price currently is worth 21% less than the NAV per share.

These discounted BDCs have small market values due to the fact the businesses are just shrinking away. If you want to own some BDC shares for the attractive dividend yields consider these three which all trade at premiums to the per share NAVs.

Triangle Capital Corporation (NYSE: TCAP) yields 9.5% and has a $760 million market value. The TCAP share price is at a 26% premium to NAV.
Golub Capital BDC Inc. (NASDAQ: GBDC) has a $1.1 billion market value and yields 6.5%. GBDC shares are also worth a 26% premium to NAV.
Hercules Capital, Inc. (Nasdaq: THTGC) yields 8.2% and has a $1.25 billion market value. HTGC is currently trading at a 53% premium to its per share NAV.

Owning high-yield stocks with secure cash flow streams like the three BDCs above allows me and my subscribers to stop worrying about the daily gyrations of the stock market because we earn consistent returns, paid in the form of cash. It's so easy, all you have to do is buy shares in the stocks that I recommend and research and watch as they deposit money into your brokerage account multiple times a year.

"It is curious that physical courage should be so common in the world and moral courage so rare." ― Mark Twain

I hope you enjoyed Tim's current take on the BDC space. This afternoon, we will look at three biotech stocks that should do well in the second quarter of this year.

Note: If you are not registered to receive the several free & detailed reports on biotech & biopharma stocks I put out every month via biotechfreereports.com, there is always times to do so. Just register HERE and all reports will then hit your "in" automatically as published.

Thank You and Happy Hunting

Bret Jensen

Founder, Biotech Forum & Insiders Forum